Naftidrofuryl in Chronic Arterial Disease Results of a Six Month Controlled Multicenter Study Using Naftidrofuryl Tablets 200 mg

Angiology

Volumn 37, Issue 3, 1986, Pages 160-167

  Adhoute, G ^a   Bacourt, F ^a   Barral, M ^a   Cardon, J M ^a   Chevalier, J M ^a   Cuny, A ^a   Gillet, M ^a   Juhan, C ^a   Leguay, G ^a   Marion, J ^a   Marie, J ^a   Natali, J ^a   Nicaise, H ^a   Plagnol, P ^a   Revelin, P ^a   Rouffy, S ^a   Saulnier, J P ^a   Schmidt, C ^a   Vasseur, J J ^a  

^a Division Oberval   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NAFTIDROFURYL; PLACEBO;

DOPPLER FLOWMETER; DRUG DOSE; DRUG EFFICACY; DRUG THERAPY; DRUG TOLERANCE; GREAT BLOOD VESSEL; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MUSCULOSKELETAL SYSTEM; ORAL DRUG ADMINISTRATION; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; SYMPTOM; THERAPY;

ADMINISTRATION, ORAL; ADULT; AGED; ARTERIOSCLEROSIS; CHRONIC DISEASE; CLINICAL TRIALS; DOUBLE-BLIND METHOD; FEMALE; FURANS; GAIT; HEMODYNAMIC PROCESSES; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; NAFRONYL; TABLETS;

EID: 0022655116     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/000331978603700304     Document Type: Article

References (11)

1. Fontaine L., Grand M., Szarvasi E., Bayssat M.: Etude de l'activité vasodilatatrice du Naftidrofuryl. Bulletin de Chimie Thérapeutique 4: 39-43, 1969.
2. Elert O., Niebel W., Krause E., Satter P.: Beeinflussung des Energiestoffwechsels der minderdurchbluteten Extremitätenmuskulatur durch Naftidrofuryl. Thierapiewoche 26: 3947-3950, 1976.
3. Becker HM, Elert O., Haring R., et al: Wirksamkeitsnachweis von Dusodril Pi bei peripherer Verschlusskrankheit. Med Welt 30: 1502-1606, 1979.
4. Kriessmann A., Neiss A., Lutilsky L., et al: Medikamentöse Behandlung der Claudicatio intermittens im Stadium II b der arteriellen Verschlusskrankheit. Med Welt 30: 888-891, 1979.
5. Pohle W., Hirche H., Barmeyer J., et al: Doppelblindstudie mit Naftidrofuryl-Hydrogenoxalat bei Patienten mit peripherer arteriellen Verschlusskrankheit. Med Welt 30: 269-272, 1979.
6. Clyne Cac, Galland RB, Fox MJ, et al: A controlled trial of Naftidrofuryl (Praxilene) in the treatment of intermittent claudication. Br J Surg 67: 347-348, 1980.
7. Trubestein G., Bohme H., Heidrich H., et al: Naftidrofuryl in chronic arterial disease. Results of a controlled multicenter study. Angiology 35: 701-708, 1984.
8. Krahenbuhl B.: L'étude à double insu, une méthode efficace de traitement? Médecine et Hygiène 41-1501: 147-148, 1983.
9. Quick Crg, Cotton LT: The measured effect of stopping smoking on intermittent claudication. Br J Surg 69: S24-S26, 1982.
10. Cristol R.: Les artériopathies des membres infériuers. Documentation Scientifique Oberval (Ed. Oberval— 1981).
11. Levy JB, Gedeon A.: Les artériopathies au stade de la claudication intermittente. Rapport présenté au 79ème congrès français de chirurgie. Monographies de l'Association Française de Chirurgie. Masson, 1977.